Jeffery Kutok Net Worth & Insider Trades

Jeffery Kutok - Chief Scientific Officer, Infinity Pharmaceuticals, Inc

As of January 13, 2020

What is Jeffery Kutok's Net Worth?

The current estimated net worth of Infinity Pharmaceuticals, Inc's Chief Scientific Officer, Jeffery Kutok, is estimated to be about $159.65K . Jeffery Kutok owns about 9,542 units of Infinity Pharmaceuticals, Inc common stock. In the last 3 years at Infinity Pharmaceuticals, Inc, Jeffery Kutok has sold an estimated value of $57.38K worth.

What is Jeffery Kutok's Past Insider Trading?

Jeffery Kutok's largest sale order was 14,313 units , worth over $28.69K on June 25, 2018. In total, Jeffery Kutok has made about 7 transactions over 3 years of their time at Infinity Pharmaceuticals, Inc. Jeffery Kutok usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 14,313 units , worth over $28.69K on August 17, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jeffery Kutok's' Mailing Address?

  • Mailing address is 784 Memorial Drive Cambridge MA 02139 MA

Infinity Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Adelene Q. Perkins 2020 $689,585 - $193,918 $1,399,928 $448,230 $11,429 $2,743,090
Adelene Q. Perkins 2019 $689,585 $61,250 - $552,480 $366,370 $11,172 $1,680,857
Lawrence E. Bloch, M.D., J.D. 2020 $488,014 - $103,946 $966,961 $244,007 $10,425 $1,813,353
Lawrence E. Bloch, M.D., J.D. 2019 $488,014 - - $459,553 $204,235 $9,366 $1,161,168
Seth A. Tasker, J.D 2020 $386,159 - $66,923 $818,913 $154,463 $8,986 $1,435,444
Seth A. Tasker, J.D 2019 $367,770 - - $138,012 $138,330 $8,820 $652,932
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1113148/000114036121014200/nc10021449x1_def14a.htm

What are Infinity Pharmaceuticals, Inc's Past Insider Trades?

Infinity Pharmaceuticals, Inc's most recent insider trade came on August 4, 2022 by Stephane Peluso who bought 64,994 units worth $9.93K . In the last 15 years, insiders at Infinity Pharmaceuticals, Inc have sold an estimated value of $486.71M and bought an estimated value of $209.8M worth of shares. Insider trading is most common in January, with the busiest year in 2012. The most active traders at the company are Adelene Perkins, Chief Executive Officer,  Anthony B Evnin,  and Michael Venuti, Director .

INFINITY PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1